Zobrazeno 1 - 10
of 170
pro vyhledávání: '"JA Woyach"'
Autor:
JR Brown, JA Woyach, K Patel, TA Eyre, Cy Cheah, P Ghia, W Jurczak, P Abada, WG Wierda, GFPN Presenter
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S160-S161 (2023)
Objectives: Pirtobrutinib, a highly selective, non-covalent (reversible) BTKi, demonstrated efficacy in patients (pts) with CLL/SLL who were resistant to cBTKi. Mechanisms of resistance to pirtobrutinib have not been systematically analyzed. We explo
Externí odkaz:
https://doaj.org/article/43125f7a7ab448c9b04516b977b0e407
Autor:
Shah NN; Medical College of Wisconsin, Milwaukee, WI. nishah@mcw.edu., Wang M; MD Anderson Cancer Center, Houston, TX., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY., Patel K; Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Wierda WG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Ujjani CS; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford., Zinzani PL; Institute of Hematology 'Seragnoli' University of Bologna, Bologna., Alencar AJ; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Ghia P; Universita Vita-Salute San Raffaele, Milano, Italy; IRCCS Ospedale San Raffaele, Milano., Lamanna N; New York-Presbyterian Columbia University Medical Center, New York, NY., Hoffmann MS; Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL., Flinn I; Sarah Cannon Research Institute, Nashville, TN., Gerson JN; Lymphoma Program, Abramson Cancer Center, Philadelphia, PA., Ma S; Robert H. Lurie Comprehensive Cancer Center, Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL., Coombs CC; University of California Irvine, Irvine, CA., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth., Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Fakhri B; Division of Hematology at Stanford University School of Medicine, Stanford, CA., Kim WS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul., Barve MA; Mary Crowley Cancer Research Center, Dallas, TX., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Munir T; Department of Haematology, St. James's University Hospital, Leeds., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, NY., Tsai DE; Loxo@Lilly, Indianapolis, IN., Bao K; Loxo@Lilly, Indianapolis, IN., Cangemi NA; Loxo@Lilly, Indianapolis, IN., Kherani JF; Loxo@Lilly, Indianapolis, IN., Walgren RA; Loxo@Lilly, Indianapolis, IN., Han H; Loxo@Lilly, Indianapolis, IN., Ruppert AS; Eli Lilly and Company, Indianapolis, IN., Brown JR; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.
Autor:
Lamanna N; Herbert Irving Comprehensive Cancer Center Columbia University New York New York USA., Tam CS; Alfred Health Melbourne Victoria Australia.; Central Clinical School Monash University Melbourne Victoria Australia., Woyach JA; Division of Hematology The Ohio State University Comprehensive Cancer Center Columbus Ohio USA., Alencar AJ; Sylvester Comprehensive Cancer Center University of Miami, Miller School of Medicine Miami Florida USA., Palomba ML; Memorial Sloan Kettering Cancer Center New York New York USA., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli' Bologna Italy.; Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna Bologna Italy., Flinn IW; Tennessee Oncology and OneOncology Nashville Tennessee USA., Fakhri B; Division of Hematology and Oncology University of California San Francisco California USA., Cohen JB; Winship Cancer Institute Emory University Atlanta Georgia USA., Kontos A; Loxo@Lilly Indianapolis Indiana USA., Konig H; Loxo@Lilly Indianapolis Indiana USA., Ruppert AS; Eli Lilly and Company Indianapolis Indiana USA., Chatterjee A; Loxo@Lilly Indianapolis Indiana USA., Sizelove R; Eli Lilly and Company Indianapolis Indiana USA., Compte L; Eli Lilly and Company Indianapolis Indiana USA., Tsai DE; Loxo@Lilly Indianapolis Indiana USA., Jurczak W; Department of Clinical Oncology Maria Sklodowska-Curie National Research Institute of Oncology Krakow Poland.
Publikováno v:
EJHaem [EJHaem] 2024 Sep 27; Vol. 5 (5), pp. 929-939. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).
Autor:
Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Cheah CY; Linear Clinical Research, Sir Charles Gairdner Hospital, University of Western Australia, Perth, Australia., Coombs CC; Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, Orange, CA., Shah NN; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Wierda WG; MD Anderson Cancer Center, Houston, TX., Patel MR; Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL., Lamanna N; Columbia University Irving Medical Center, NewYork-Presbyterian, New York, NY., Tsai DE; Loxo@Lilly, Indianapolis, IN., Nair B; Loxo@Lilly, Indianapolis, IN., Wang C; Eli Lilly and Company, Indianapolis, IN., Zhao X; Loxo@Lilly, Indianapolis, IN., Liu D; Eli Lilly and Company, Indianapolis, IN., Radtke D; Eli Lilly and Company, Indianapolis, IN., Chapman S; Eli Lilly and Company, Indianapolis, IN., Marella N; Loxo@Lilly, Indianapolis, IN., McNeely SC; Loxo@Lilly, Indianapolis, IN., Brown JR; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Publikováno v:
Blood [Blood] 2024 Sep 26; Vol. 144 (13), pp. 1374-1386.
Autor:
Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Jones D; The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Department of Pathology, The Ohio State University, Columbus, OH., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Robak T; Medical University of Lodz, and Copernicus Memorial Hospital, Lodz, Poland., Illés Á; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, on behalf of HOVON, Amsterdam, The Netherlands., Ghia P; Università Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Byrd JC; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH., Seymour JF; Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia., Long S; The Ohio State University Wexner Medical Center James Molecular Laboratory, Columbus, OH., Mohamed N; Department of Pathology, The Ohio State University, Columbus, OH., Benrashid S; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Lai TH; The Ohio State University Comprehensive Cancer Center, Columbus, OH., De Jesus G; AstraZeneca, South San Francisco, CA., Lai R; AstraZeneca, South San Francisco, CA., de Bruin G; Acerta Pharma BV, a member of the AstraZeneca group, Oss, The Netherlands., Rule S; AstraZeneca, Mississauga, ON, Canada., Munugalavadla V; AstraZeneca, South San Francisco, CA.
Publikováno v:
Blood [Blood] 2024 Sep 05; Vol. 144 (10), pp. 1061-1068.
Autor:
Wierda WG; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: wwierda@mdanderson.org., Shah NN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WA, Australia., Lewis D; Plymouth Hospitals NHS Trust, Derriford Hospital, Plymouth, UK., Hoffmann MS; The University of Kansas Cancer Center, Kansas City, KS, USA., Coombs CC; University of California Irvine Health, Chao Family Comprehensive Cancer Center, Orange, CA, USA., Lamanna N; Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA., Ma S; Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Jagadeesh D; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Munir T; Department of Haematology, St James's University Hospital, Leeds, UK., Wang Y; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, UK., Rhodes JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., McKinney M; Duke Cancer Institute, Durham, NC, USA., Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Tam CS; Alfred Hospital and Monash University, Melbourne, Australia., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Izutsu K; National Cancer Center Hospital, Tokyo, Japan., Alencar AJ; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA., Patel MR; Florida Cancer Specialists and Sarah Cannon Research Institute, Sarasota, FL, USA., Seymour JF; Alfred Hospital and Monash University, Melbourne, Australia., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Thompson PA; Alfred Hospital and Monash University, Melbourne, Australia., Abada PB; Loxo Oncology, Indianapolis, IN, USA., Ho C; Loxo Oncology, Indianapolis, IN, USA., McNeely SC; Loxo Oncology, Indianapolis, IN, USA., Marella N; Loxo Oncology, Indianapolis, IN, USA., Nguyen B; Loxo Oncology, Indianapolis, IN, USA., Wang C; Eli Lilly, Indianapolis, IN, USA., Ruppert AS; Eli Lilly, Indianapolis, IN, USA., Nair B; Loxo Oncology, Indianapolis, IN, USA., Liu H; Loxo Oncology, Indianapolis, IN, USA., Tsai DE; Loxo Oncology, Indianapolis, IN, USA., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ghia P; Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Sep; Vol. 11 (9), pp. e682-e692. Date of Electronic Publication: 2024 Jul 18.
Autor:
Ravikrishnan J; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Diaz-Rohena DY; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston TX., Muhowski E; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Mo X; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH., Lai TH; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Misra S; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Williams CD; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston TX., Sanchez J; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston TX., Mitchell A; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Satpati S; Department of Genomic Medicine, MD Anderson Cancer Center, Houston TX., Perry E; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Kaufman T; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Liu C; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston TX., Lozanski A; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Lozanski G; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Rogers K; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Bhat SA; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Collins MC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jain N; Department of Leukemia, MD Anderson Cancer Center, Houston TX., Wierda WG; Department of Leukemia, MD Anderson Cancer Center, Houston TX., Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH., Tan F; Newave Pharmaceutical Inc., Pleasanton, CA., Chen Y; Newave Pharmaceutical Inc., Pleasanton, CA., Chen Y; Newave Pharmaceutical Inc., Pleasanton, CA., Shen Y; Newave Pharmaceutical Inc., Pleasanton, CA., Anthony SP; Newave Pharmaceutical Inc., Pleasanton, CA., Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH. Jennifer.Woyach@osumc.edu., Sampath D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston TX. DSampath@mdanderson.org.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Autor:
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Sharman JP; Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR., Ghia P; Division of Experimental Oncology, Università Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Eyre TA; Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Jurczak W; Maria Skłodowska-Curie National Research Institute of Oncology, Krakow, Poland., Siddiqi T; City of Hope Comprehensive Cancer Center, Duarte, CA., Miranda P; AstraZeneca, Gaithersburg, MD., Shahkarami M; AstraZeneca, South San Francisco, CA., Butturini A; AstraZeneca, South San Francisco, CA., Emeribe U; AstraZeneca, Gaithersburg, MD., Byrd JC; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3345-3359.
Autor:
Merchand-Reyes G; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Bull MF; College of Medicine, The Ohio State University, Columbus, OH, United States., Santhanam R; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Valencia-Pena ML; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Murugesan RA; College of Medicine, The Ohio State University, Columbus, OH, United States., Chordia A; College of Medicine, The Ohio State University, Columbus, OH, United States., Mo XM; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Robledo-Avila FH; Center for Microbial Pathogenesis, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States., Ruiz-Rosado JD; Kidney and Urinary Tract Center, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Pediatric Nephrology and Hypertension, Nationwide Children's Hospital, Columbus, OH, United States., Carson WE 3rd; Department of Surgery, The Ohio State University, Columbus, OH, United States., Byrd JC; Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, United States., Woyach JA; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Tridandapani S; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Butchar JP; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 11; Vol. 15, pp. 1409333. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).
Autor:
Kittai AS; Division of Hematology, The Ohio State University, Columbus, OH., Bond D; Division of Hematology, The Ohio State University, Columbus, OH., Huang Y; Division of Hematology, The Ohio State University, Columbus, OH., Bhat SA; Division of Hematology, The Ohio State University, Columbus, OH., Blyth E; Blood Transplant and Cell Therapies Program, Westmead Hospital Department of Haematology, Westmead, NSW, Australia., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Dela Cruz JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Dowling MR; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Melbourne, Australia., Duffy C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Ho C; Clinical Research Division, Fred Hutchinson Cancer Center and University of Washington, Seattle, WA., Jacobson C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Jaglowski S; Division of Hematology, The Ohio State University, Columbus, OH., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Lin KH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Miller C; Department of Pathology, The Ohio State University, Columbus, OH., McCarthy C; Department of Hematology, Department of Clinical Informatics, City of Hope National Medical Center, Duarte, CA., Omer Z; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH., Parry E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rai M; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Rogers KA; Division of Hematology, The Ohio State University, Columbus, OH., Saha A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Schachter L; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Scott H; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Shadman M; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Melbourne, Australia., Siddiqi T; Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA., Stephens DM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Vanguru V; Institute of Haematology, Royal Prince Alfred Hospital, NSW, Australia., Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH., Thompson PA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Melbourne, Australia.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 10; Vol. 42 (17), pp. 2071-2079. Date of Electronic Publication: 2024 Mar 29.